147 related articles for article (PubMed ID: 33502684)
1. OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/KLF7 axis in PLCA patients.
Liu J; Chen J; Zhong Y; Yu X; Lu P; Feng J; Zhang X; Ma S; Yang C; Yang B; Rong Z
Protein Cell; 2021 Aug; 12(8):653-661. PubMed ID: 33502684
[No Abstract] [Full Text] [Related]
2. AHNAK, regulated by the OSM/OSMR signaling, involved in the development of primary localized cutaneous amyloidosis.
Liu H; Qiu B; Yang H; Zheng W; Luo Y; Zhong Y; Lu P; Chen J; Luo Y; Liu J; Yang B
J Dermatol Sci; 2023 May; 110(2):53-60. PubMed ID: 37100691
[TBL] [Abstract][Full Text] [Related]
3. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis.
Tanaka A; Arita K; Lai-Cheong JE; Palisson F; Hide M; McGrath JA
Br J Dermatol; 2009 Dec; 161(6):1217-24. PubMed ID: 19663869
[TBL] [Abstract][Full Text] [Related]
4. A new c.1845A→T of oncostatin M receptor-β mutation and slightly enhanced oncostatin M receptor-β expression in a Chinese family with primary localized cutaneous amyloidosis.
Wang WH; Li LF; Huang ES; Zhang Q; Sun TT; Song QH; Xu ML; Chen XR
Eur J Dermatol; 2012; 22(1):29-33. PubMed ID: 22062952
[TBL] [Abstract][Full Text] [Related]
5. A novel oncostatin M/interleukin-31 receptor mutation in familial primary localized cutaneous amyloidosis.
Adams R; Colmont C; Mukhtar A; Morgan H; Patel GK
Clin Exp Dermatol; 2020 Mar; 45(2):254-256. PubMed ID: 31478212
[No Abstract] [Full Text] [Related]
6. Familial primary localized cutaneous amyloidosis in a Japanese family.
Ueo D; Utani A; Okubo Y; Yozaki M; Mine Y; Anan T; Nishida H; Takahashi D; Sakai T; Hatano Y; Fujiwara S
J Dermatol Sci; 2016 Aug; 83(2):162-4. PubMed ID: 27289340
[No Abstract] [Full Text] [Related]
7. Identification of an oncostatin M receptor mutation associated with familial primary cutaneous amyloidosis.
Babilas P; Fiebig BS; Aslanidis C; Hansen J; Röcken C; Schroeder J; Schmitz G; Weber BH; Landthaler M; Vogt T
Br J Dermatol; 2009 Oct; 161(4):944-7. PubMed ID: 19466957
[No Abstract] [Full Text] [Related]
8. The molecular skin pathology of familial primary localized cutaneous amyloidosis.
Tanaka A; Lai-Cheong JE; van den Akker PC; Nagy N; Millington G; Diercks GF; van Voorst Vader PC; Clements SE; Almaani N; Techanukul T; Hide M; South AP; McGrath JA
Exp Dermatol; 2010 May; 19(5):416-23. PubMed ID: 20507362
[TBL] [Abstract][Full Text] [Related]
9. MCP-1 as an effector of IL-31 signaling in familial primary cutaneous amyloidosis.
Shiao YM; Chung HJ; Chen CC; Chiang KN; Chang YT; Lee DD; Lin MW; Tsai SF; Matsuura I
J Invest Dermatol; 2013 May; 133(5):1375-8. PubMed ID: 23303452
[No Abstract] [Full Text] [Related]
10. Clinical and genetic features of Chinese patients with lichen and macular primary localized cutaneous amyloidosis.
Lu P; Wu FF; Rong ZL; Fang C; Deng CC; Bin LH; Yang B
Clin Exp Dermatol; 2019 Jun; 44(4):e110-e117. PubMed ID: 30734345
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis.
Arita K; South AP; Hans-Filho G; Sakuma TH; Lai-Cheong J; Clements S; Odashiro M; Odashiro DN; Hans-Neto G; Hans NR; Holder MV; Bhogal BS; Hartshorne ST; Akiyama M; Shimizu H; McGrath JA
Am J Hum Genet; 2008 Jan; 82(1):73-80. PubMed ID: 18179886
[TBL] [Abstract][Full Text] [Related]
12. Generation of a human embryonic stem cell line (SMUDHe010-A-82) carrying a homozygous c.1538G > A (p.G513D) mutation in the OSMR gene by CRISPR/Cas9-mediated homologous recombination.
Zheng W; Zhong Y; Yuan L; Yu X; Wang X; Yang C; Liu H; Lv P; Luo Y; Qiu B; Liu J; Yang B
Stem Cell Res; 2022 Aug; 63():102842. PubMed ID: 35714449
[TBL] [Abstract][Full Text] [Related]
13. A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.
Saeedi M; Ebrahim-Habibi A; Haghighi A; Zarrabi F; Amoli MM; Robati RM
Biomed Res Int; 2014; 2014():653724. PubMed ID: 25054142
[TBL] [Abstract][Full Text] [Related]
14. Lack of oncostatin M receptor β leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype.
Komori T; Tanaka M; Senba E; Miyajima A; Morikawa Y
J Biol Chem; 2013 Jul; 288(30):21861-75. PubMed ID: 23760275
[TBL] [Abstract][Full Text] [Related]
15. A Th2 cytokine interleukin-31 signature in a case of sporadic lichen amyloidosis.
Dousset L; Seneschal J; Boniface K; Charreau S; Ezzedine K; Milpied B; Mossalayi MD; McGrath JA; Lecron JC; Taïeb A
Acta Derm Venereol; 2015 Feb; 95(2):223-4. PubMed ID: 24573820
[No Abstract] [Full Text] [Related]
16. Familial primary localized cutaneous amyloidosis results from either dominant or recessive mutations in OSMR.
Wali A; Liu L; Takeichi T; Jelani M; Rahman OU; Heng YK; Thng S; Lee J; Akiyama M; McGrath JA; Betz RC
Acta Derm Venereol; 2015 Nov; 95(8):1005-7. PubMed ID: 25792357
[No Abstract] [Full Text] [Related]
17. RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D.
Qi XP; Zhao JQ; Chen ZG; Cao JL; Du J; Liu NF; Li F; Sheng M; Fu E; Guo J; Jia H; Zhang YM; Ma JM
Oncotarget; 2015 Oct; 6(32):33993-4003. PubMed ID: 26356818
[TBL] [Abstract][Full Text] [Related]
18. Sex differences of Chinese patients with primary localized cutaneous amyloidosis.
Lu P; Wu F; Man M; Rong Z; Zhang Y; Yang B
J Dermatol; 2019 Jul; 46(7):e242-e243. PubMed ID: 30740762
[No Abstract] [Full Text] [Related]
19. [Identification of pathogenic mutations in two Chinese families affected with primary localized cutaneous amyloidosis].
Mao B; Yao X; Wang Z; Zhao X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Feb; 35(1):9-13. PubMed ID: 29419851
[TBL] [Abstract][Full Text] [Related]
20. Familial primary localized cutaneous amyloidosis with an oncostatin M receptor-β mutation, Pro694Leu.
Schreml S; Weber BH; Schröder J; Siegmund H; Schaller J; Vogt T; Landthaler M; Schönbuchner I; Röcken C; Babilas P
Clin Exp Dermatol; 2013 Dec; 38(8):932-5. PubMed ID: 23692662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
